News
DRTSW
0.3700
+8.82%
0.0300
Weekly Report: what happened at DRTSW last week (1222-1226)?
Weekly Report · 12/29/2025 09:54
Weekly Report: what happened at DRTSW last week (1215-1219)?
Weekly Report · 12/22/2025 09:54
Alpha Tau Medical to Present Corporate Update at J.P. Morgan Healthcare Conference
Reuters · 12/18/2025 14:01
Weekly Report: what happened at DRTSW last week (1208-1212)?
Weekly Report · 12/15/2025 09:59
ALPHA TAU MEDICAL LTD - TREATS FIRST PATIENT IN GLIOBLASTOMA STUDY
Reuters · 12/09/2025 14:04
Alpha Tau Medical Treats First Glioblastoma Patient with Alpha DaRT in U.S. Trial
Reuters · 12/09/2025 14:00
Weekly Report: what happened at DRTSW last week (1201-1205)?
Weekly Report · 12/08/2025 09:58
Alpha Tau Medical Launches U.S. Clinical Trial of Alpha DaRT for Pancreatic Cancer
Reuters · 12/04/2025 14:00
Alpha Tau Medical Wins FDA Approval to Begin Prostate Cancer Trial
Reuters · 12/02/2025 14:00
ALPHA TAU RECEIVES FDA APPROVAL TO INITIATE A TRIAL FOR PATIENTS WITH LOCALLY RECURRENT PROSTATE CANCER
Reuters · 12/02/2025 14:00
Weekly Report: what happened at DRTSW last week (1124-1128)?
Weekly Report · 12/01/2025 09:55
Weekly Report: what happened at DRTSW last week (1117-1121)?
Weekly Report · 11/24/2025 09:59
Alpha Tau Medical reports third quarter 2025 financial results
Reuters · 11/20/2025 21:08
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Barchart · 11/20/2025 15:05
Oramed Pharmaceuticals reports $65 million net income for nine months ended September 2025
Reuters · 11/17/2025 13:56
Weekly Report: what happened at DRTSW last week (1110-1114)?
Weekly Report · 11/17/2025 09:59
Weekly Report: what happened at DRTSW last week (1103-1107)?
Weekly Report · 11/10/2025 09:57
Weekly Report: what happened at DRTSW last week (1027-1031)?
Weekly Report · 11/03/2025 09:57
Weekly Report: what happened at DRTSW last week (1020-1024)?
Weekly Report · 10/27/2025 09:59
ALPHA TAU MEDICAL LTD - AIMING TO PRODUCE ALPHA DART TREATMENTS IN HUDSON FACILITY IN 2026
Reuters · 10/21/2025 12:31
More
Webull provides a variety of real-time DRTSW stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTSW
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.